Showing results (1-10 of 87) with videos related to
Sort By:
Pageof 9
Journal of Clinical Microbiology|August 28, 2009
Comparison of the Xpert methicillin-resistant Staphylococcus aureus (MRSA) assay, BD GeneOhm MRSA assay, and culture for detection of nasal and cutaneous groin colonization by MRSAP G Kelley, E A Grabsch, B P Howden, et al.European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 1, 2005
Low-level vancomycin resistance in Staphylococcus aureus--an Australian perspectiveB P Howden, P B Ward, P D R Johnson, et al.Internal Medicine Journal|November 8, 2005
Recognition and management of infections caused by vancomycin-intermediate Staphylococcus aureus (VISA) and heterogenous VISA (hVISA)B P HowdenEpidemiology and Infection|November 6, 2014
Impact of vanB vancomycin-resistant enterococcal bacteraemia analysed as a time-varying covariate on length of hospital stayA L Y Cheah, T Spelman, T Peel, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 13, 2013
Enterococcal bacteraemia: factors influencing mortality, length of stay and costs of hospitalizationA L Y Cheah, T Spelman, D Liew, et al.The Journal of Antimicrobial Chemotherapy|August 2, 2001
The efficacy of continuous infusion flucloxacillin in home therapy for serious staphylococcal infections and cellulitisB P Howden, M J RichardsInternal Medicine Journal|November 8, 2005
Diagnosis and management of Staphylococcus aureus bacteraemiaD H Mitchell, B P HowdenAntimicrobial Agents and Chemotherapy|June 10, 2009
Prospective comparison of the clinical impacts of heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-susceptible MRSAK C Horne, B P Howden, E A Grabsch, et al.Infectious Disease Clinics of North America|March 1, 1995
Diabetic foot infections. Antimicrobial therapyM L GraysonPageof 9